BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32243925)

  • 1. Karyopherin α 2 promotes proliferation, migration and invasion through activating NF-κB/p65 signaling pathways in melanoma cells.
    Yang F; Li S; Cheng Y; Li J; Han X
    Life Sci; 2020 Jul; 252():117611. PubMed ID: 32243925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karyopherin Alpha 2 Promotes the Inflammatory Response in Rat Pancreatic Acinar Cells Via Facilitating NF-κB Activation.
    Cai Y; Shen Y; Gao L; Chen M; Xiao M; Huang Z; Zhang D
    Dig Dis Sci; 2016 Mar; 61(3):747-57. PubMed ID: 26526450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.
    Duan M; Hu F; Li D; Wu S; Peng N
    Life Sci; 2020 Jul; 253():117736. PubMed ID: 32360571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KPNA2 interacts with P65 to modulate catabolic events in osteoarthritis.
    Tao R; Xu X; Sun C; Wang Y; Wang S; Liu Z; Zhai L; Cheng H; Xiao M; Zhang D
    Exp Mol Pathol; 2015 Oct; 99(2):245-52. PubMed ID: 26209501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX4 promotes melanoma cell migration and invasion though the activation of the NF-κB signaling pathway.
    Cheng Q; Wu J; Zhang Y; Liu X; Xu N; Zuo F; Xu J
    Int J Mol Med; 2017 Aug; 40(2):447-453. PubMed ID: 28627651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
    Zan Y; Wang B; Liang L; Deng Y; Tian T; Dai Z; Dong L
    J Exp Clin Cancer Res; 2019 May; 38(1):182. PubMed ID: 31046781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
    Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
    Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
    Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
    Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
    Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
    Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
    Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
    Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
    Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
    Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling.
    Hai L; Liu P; Yu S; Yi L; Tao Z; Zhang C; Abeysekera IR; Li T; Tong L; Ma H; Liu B; Xie Y; Zhou X; Lin Y; Zhu M; Zhang K; Ren B; Ming H; Huang Y; Yang X
    Cell Physiol Biochem; 2018; 51(6):2925-2937. PubMed ID: 30580328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET inhibitor suppresses melanoma progression
    Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
    Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
    [No Abstract]   [Full Text] [Related]  

  • 15. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
    Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
    Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB.
    Xie B; Cao K; Li J; Chen J; Tang J; Chen X; Xia K; Zhou X; Cheng Y; Zhou J; Xie H
    Oncotarget; 2016 Dec; 7(49):80765-80782. PubMed ID: 27779100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KPNA2 Contributes to the Inflammatory Processes in Synovial Tissue of Patients with Rheumatoid Arthritis and SW982 Cells.
    Liu Z; Zhang D; Sun C; Tao R; Xu X; Xu L; Cheng H; Xiao M; Wang Y
    Inflammation; 2015 Dec; 38(6):2224-34. PubMed ID: 26135850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
    Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
    J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_PABPC1 promotes the malignancy of gastric cancer through interacting with ILK to activate NF-κB pathway.
    Yan S; Wang Z; Lan D; Niu J; Jian X; He F; Tang W; Hu C; Liu W
    Exp Cell Res; 2024 May; 438(2):114058. PubMed ID: 38688434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.